Effect of Dashmoola Katutrayadi Syrup in the management of Respiratory Allergies in Childre
Phase 3
- Conditions
- Health Condition 1: J069- Acute upper respiratory infection,unspecified
- Registration Number
- CTRI/2024/02/062324
- Lead Sponsor
- O ANY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Children having cardinal features of respiratory allergy
2.History of at least three episodes in last one year
3.Age group 6-12 years
Exclusion Criteria
1.Severe and complicated cases of respiratory allergies requiring hospitalization
2.Diagnosed case of Tuberculosis, Plural effusion, Emphysema, Lung abscess, Bronchiectasis, Pleurisy, Nasal polyps, Congenital lung/cardiac anomalies
3.Chronic debilitating diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Change in Serum IgETimepoint: 8 weeks
- Secondary Outcome Measures
Name Time Method 1.Change in peak expiratory flow rate (PEFR) <br/ ><br>2.Change in CBC, ESR, TEC <br/ ><br>3.Change in Morbidity score <br/ ><br>4.Change in quality of life <br/ ><br>Timepoint: 8 Weeks